When is a coeliac a coeliac? Report of a working group of the United European Gastroenterology Week in Amsterdam, 2001

European Journal of Gastroenterology and Hepatology

Volumn 13, Issue 9, 2001, Pages 1123-1128

  Mudler, C J J ^a  

^a RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

Coeliac disease; Diagnosis; Gluten contamination; Gluten free diet; Histology; Immunogenetics; Refractory coeliac disease; Therapy

Indexed keywords

LEUKOCYTE ANTIGEN;

CELIAC DISEASE; ENVIRONMENTAL FACTOR; GLUTEN FREE DIET; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNOGENETICS; JEJUNUM MUCOSA; LYMPHOCYTE PROLIFERATION; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TISSUE INJURY;

CELIAC DISEASE; EUROPE; FEMALE; GASTROENTEROLOGY; HUMANS; MALE;

EID: 0034813343     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200109000-00023     Document Type: Review

References (40)

1. Diagnostic criteria in coeliac disease
2. Definition of coeliac disease in children
3. Revised criteria for diagnosis of coeliac disease
4. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunologic approach to the spectrum of gluten sensitivity (celiac sprue)
5. Sensitivity of anti-endomysium and antigliadin antibodies in untreated celiac disease: Disappointing in clinical practice
6. Slow and incomplete histological and functional recovery in adult gluten sensitive enteropathy
7. Wheat starch-containing gluten free flour products in the treatment of coeliac disease and dermatitis herpetiformis. A long term follow-up study
8. Follow-up of treated coeliac patients: Sugar absorption test and intestinal biopsies compared
9. Pitfalls in diagnosing coeliac disease
10. Coeliac disease in the year 2000: Exploring the iceberg
11. An iceberg of childhood coeliac disease in the Netherlands
12. Celiac disease risk in the USA: High prevalence of antiendomysium antibodies in healthy blood donors
13. How many hospital visits does it take before celiac sprue is diagnosed?
14. Diagnosis of coeliac disease
15. Reliance on serum endomysial antibody testing underestimates the true prevalence of coeliac disease by one fifth
16. Disappearance of endomysial antibodies in treated coeliac disease does not indicate histological recovery
17. IgA endomysium antibody: A valuable tool in the screening of coeliac disease, but not in its follow-up
18. Is human umbilical cord the most suitable substrate for the detection of endomysium antibodies in the screening and follow up of coeliac disease?
19. Identification of tissue transglutaminase as the autoantigen of celiac disease
20. Current concepts of celiac disease pathogenesis
21. Human tissue transaminase ELISA: A powerful mass screening diagnostic assay for celiac disease
22. Atypical coeliac disease found with serologic screening
23. Current approaches to diagnosis and treatment of celiac disease: An evolving spectrum
24. Endoscopic demonstration of loss of duodenal folds in the diagnosis of celiac disease
25. Disappointing sensitivity of endoscopic markers for villous atrophy in a high-risk population: Implications for celiac disease diagnosis during routine endoscopy
26. Evidence for a primary association of celiac disease to a particular HLA-DQ α/β heterodimer
27. Small intestinal T-cells of celiac patients recognise a natural pepsin fragment of gliadin
28. Molecular basis of celiac disease
29. Accuracy and cost-effectiveness of a new strategy to screen for celiac disease in children with Down's syndrome
30. Seroconversion of reticulin autoantibodies predicts coeliac disease in insulin dependent diabetes mellitus
31. Coeliac disease
32. Persistent mucosal abnormalities in coeliac disease are not related to the ingestion of trace amounts of gluten
33. A comparison of diets with and without oats in adults with celiac disease
34. Oats and celiac disease
35. Management of patients with non-responsive coeliac disease
36. Abnormal intestinal intraepithelial lymphocytes in refractory sprue
37. Are complicated forms of celiac disease cryptic T-cell lymphomas?
38. Osteopenia in patients with clinically silent coeliac disease warrants screening
39. Coeliac disease and its management